An Independent Review

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

salbutamol
  • Airomir (New formulation) 22(1) 20-3
  • in asthma 21(1) 22-4
  • Combivent - ipratropium combination (New combination) 22(6) 147-51
  • Epaq inhaler (New brand) 24(2) 43-7
  • intravenous in asthma emergencies (PBAC question) 17(2) 48
  • salivary glands
  • drug- and radiotherapy-induced xerostomia 29(4) 97-8
  • dental notes 29(4) 108
  • letters 30(1) 3-4
  • salmeterol
  • in asthma 21(1) 22-4
  • combination inhalers in asthma 28(2) 26-8
  • fluticasone propionate - Seretide Accuhaler (New combination) 23(4) 84-7
  • fluticasone propionate - Seretide MDI (New formulations) 24(4) 100-2
  • safety concerns (editorial) 29(5) 118-9
  • Salmonella typhi Vi
  • Typherix (New brand) 23(1) 21-3
  • Salofalk
  • see mesalasine 27(4) 101-5; 25(4) 94-9
  • samarium [Sm 153] lexidronam pentasodium
  • bone metastases - Quadramet (New drug) 21(2) 49-55
  • Sandostatin
  • see ocreotide 23(2) 45-6
  • Sandrena
  • see oestradiol 21(4) 108-11
  • saquinavir
  • HIV - Invirase (New drug) 19(4) 108-11
  • saw palmetto
  • benign prostatic hypertrophy 23(4) 79
  • SBPA Clozapine
  • see clozapine 23(3) 64-7
  • SBPA Fluoxetine
  • see fluoxetine 23(3) 64-7
  • SBPA Metoprolol
  • see Metoprolol tartrate 23(1) 21-3
  • SBPA Ranitidine
  • see ranitidine 23(1) 21-3
  • scabies
  • lindane toxicity (letters) 21(1) 5-8; 20(2) 31-2
  • management 23(2) 33-5
  • scheduling of drugs and poisons 20(1) 12-3
  • schizophrenia
  • amisulpride - Solian (New drug) 25(5) 120-3
  • antipsychotic drugs and risk of diabetes 27(5) 118-9
  • aripiprazole - Abilify (New drug) 26(5) 118-9
  • costs and benefits of atypical versus typical antipsychotics 27(6) 146-9; 27(6) 149-51
  • dopamine clinical pharmacology 17(2) 42-3
  • flupenthixol - Fluanxol (New drug) 17(2) 30-2
  • long-term community management 30(2) 44-6
  • new antipsychotic drugs 22(4) 81-3
  • olanzapine - Zyprexa (New drug) 20(3) 77-9
  • patient support organisations 22(4) 84
  • quetiapine fumarate - Seroquel (New drug) 23(3) 64-7
  • remoxipride - Roxiam (New drug) 17(1) 6-8
  • risperidone - Risperidal (New drug) 17(4) 87-90
  • ziprasidone - Zeldox (New drug) 30(2) 50-55
  • letter 30(3) 59-63
  • zuclopenthixol - Clopixol-Acuphase (New drug) 19(2) 38-40
  • sciatica
  • see back pain 17(2) 33-6
  • screening
  • population screening - newborn hearing 26(4) 82-4
  • Sebivo
  • see telbivudine 30(6) 163-7
  • sedation, postoperative
  • dexmedetomidine - Precedex (New drug) 24(5) 129-31
  • sedatives
  • management of insomnia 26(4) 78-81
  • letter 26(6) 124-5
  • psychotropic drugs and dentistry 30(4) 98-101
  • seizures
  • clinical use of antiepileptics 17(1) 9-12
  • drugs which lower seizure threshold 24(1) 8-9
  • rectal diazepam in children 21(2) 35-6
  • selegiline
  • dietary restrictions and tyramine interactions (letters) 17(2) 28-9
  • new brand - Selgene 20(3) 77-9
  • in Parkinson's disease 24(4) 92-5
  • Selgene
  • see selegiline 20(3) 77-9
  • semisodium valproate
  • see valproic acid 17(1) 9-12
  • Sensipar
  • see cinacalcet 28(3) 75-9
  • sepsis - see also antibiotics
  • drotrecogin alfa - Xigris (New drug) 25(6) 147-51
  • infection control and intravenous catheters 26(2) 41-3
  • letter 26(4) 75-7
  • Septanest
  • see articaine 28(1) 19-23
  • Serc
  • see betahistidine 21(2) 49-55
  • Serenoa repens
  • see saw palmetto 23(4) 79
  • Seretide
  • see salmeterol/fluticasone propionate 24(4) 100-2
  • Seretide Accuhaler
  • see salmeterol/fluticasone propionate 23(4) 84-7
  • Seroquel
  • see quetiapine fumarate 23(3) 64-7
  • serotonin agonists
  • naratriptan - migraine - Naramig (New drug) 21(4) 108-11
  • zolmitriptan - migraine - Zomig (New drug) 21(4) 108-11
  • serotonin antagonists
  • granisetron - nausea and vomiting - Kytril (New drug) 27(4) 101-5
  • irritable bowel syndrome - management 24(3) 68-71
  • mirtazapine - depression - Avanza (New drug) 24(3) 71-5
  • tegaserod - irritable bowel syndrome - Zelmac (New drug) 25(3) 74-5
  • advertising (editorial comment) 26(3) 67
  • serotonin receptor blockers
  • dolasetron - antiemetic - Anzemet (New drug) 20(4) 101-3
  • tropisetron - antiemetic - Navoban (New drug) 17(4) 87-90
  • serotonin reuptake inhibitors - see also antidepressant drugs
  • antidepressants and suicide risk in children (editorials) 28(5) 110-1; 28(5) 111-3
  • letter 29(2) 32-5
  • citalopram - Cipramil (New drug) 21(2) 49-55
  • clinical applications 22(5) 108-11
  • letter 22(6) 131-2
  • costs and benefits vs tricyclic antidepressants (editorial) 18(4) 82-4
  • depression in young people 21(1) 20-2
  • distribution in human milk 20(2) 35-40
  • escitalopram oxalate - Lexapro (New drug) 26(6) 146-51
  • letter 27(2) 28-33
  • fluvoxamine - Luvox (New drug) 20(3) 77-9
  • interaction with moclobemide 18(4) 100-1
  • letter 19(2) 36-8
  • interactions with tramadol 25(1) 19
  • nefazodone - Serzone (New drug) 20(3) 77-9
  • letter 21(1) 5-8
  • paroxetine - Aropax (New drug) 17(2) 30-2
  • pharmacology 22(5) 106-8
  • pregnancy and breastfeeding 30(5) 125-7
  • review of new antidepressants 18(4) 92-6
  • letters 19(2) 36-8
  • sertraline - Zoloft (New drug) 17(3) 73
  • serotonin syndrome
  • over-the-counter dextromethorphan 29(3) 71
  • letter 29(6) 149-50
  • serotonin syndrome 26(3) 62-3; 25(1) 19; 21(3) 63
  • letters 26(5) 99-102; 22(1) 3-5
  • tramadol adverse effects (editorial) 27(2) 26-7
  • sertindole
  • new antipsychotic drugs 22(4) 81-3
  • sertraline
  • antidepressant - Zoloft (New drug) 17(3) 73
  • authority prescription costs (PBAC question) 20(3) 60
  • splitting sertraline tablets (letter) 21(1) 5-8
  • costs and benefits of antidepressants (editorial) 18(4) 82-4
  • interactions (letter) 22(3) 53-4
  • review of new antidepressants 18(4) 92-6
  • Serzone
  • see nefazodone 21(1) 5-8; 20(3) 77-9
  • sevelamer
  • Renagel - hyperphosphataemia in chronic renal disease (New drug) 28(6) 156-8
  • sevoflurane
  • general anaesthetic - SEVOrane - (New drug) 19(2) 38-40
  • Sevorane
  • see sevoflurane 19(2) 38-40
  • sexual abuse
  • diagnosis and management of vulvovaginitis in childhood 28(4) 88-90
  • sexually transmitted infections
  • abnormal laboratory results 30(1) 8-13
  • Sheffield tables
  • cholesterol 21(4) 98-9
  • shelf life
  • expiry dates 17(2) 46-8
  • letter - intravenous infusion lines 18(3) 56-7
  • shingles
  • varicella vaccine - frequently asked questions 28(1) 2-5
  • letters 28(5) 113-5; 28(3) 55-8
  • zoster virus vaccine - Zostavax (New drug) 31(1) 24-7
  • sialogogues
  • management of xerostomia 29(4) 97-8
  • letters 30(1) 3-4
  • sibutramine
  • management of obesity 29(2) 43-7
  • obesity - Reductil (New drug) 25(1) 20-3
  • sildenafil
  • erectile dysfunction 21(2) 46-8
  • Viagra (New drug) 21(4) 108-11
  • Simulect
  • see basiliximab 22(4) 95-8
  • simvastatin
  • after myocardial infarction (editorial) 21(4) 86-7
  • hypercholesterolaemia 22(5) 114-7
  • hypercholesterolaemia (letter) 23(2) 27-8
  • and muscle symptoms 28(4) 102
  • letter 28(6) 136-9
  • new strength - Zocor 20(3) 77-9
  • Singulair
  • see montelukast 24(4) 100-2; 22(3) 58-60; 21(4) 108-11
  • sinusitis
  • amoxycillin vs Augmentin - drug advertising (letter) 17(3) 55-6
  • cephalosporins (letter) 23(6) 115-7
  • dental implications 23(2) 43
  • dental pain emergency management 24(6) 144-8
  • management 23(2) 39-42
  • letters 23(6) 115-7; 23(5) 93-6
  • sirolimus
  • pharmacology of immunosuppressants 29(4) 99-101; 29(4) 102-8
  • Rapamune (New formulation) 25(6) 147-51
  • renal transplantation - Rapamune (New drug) 25(4) 94-9
  • sitosterolaemia
  • ezetimibe - Ezetrol (New drug) 26(6) 146-51
  • Skelid
  • see tiludronate 21(3) 80-3
  • skin cancer
  • methyl-5-aminolevulinate - Metvix (New drug) 27(3) 76-9
  • topical retinoids and photosensitivity (letter) 22(4) 74-5
  • skin diseases
  • corticosteroids in dermatology 21(1) 9-11
  • mometasone - Elocon (New drug) 17(1) 6-8
  • skin infections
  • antifungal drugs 19(3) 72-5
  • flucloxacillin vs other antibiotics (editorial) 18(3) 54-6
  • letter 19(1) 3-6
  • skin prick testing
  • allergy diagnosis 25(4) 91-3
  • skin testing
  • drug allergy 17(3) 62-5
  • vaccines and egg protein allergy (letter) 18(2) 27-9
  • Skinoren
  • see azelaic acid 17(1) 6-8
  • sleep disorders - see also insomnia
  • antidepressants and non pharmacological management in the elderly 18(1) 21-2
  • diagnostic tests 21(2) 40-3
  • letter 22(1) 3-5
  • modafinil - narcolepsy - Modavigil (New drug) 25(5) 120-3
  • slow-release drugs
  • see also depot formulations 22(4) 88-90
  • smoking cessation
  • bupropion (PBAC question) 24(3) 64
  • bupropion - Zyban (New drug) 24(1) 20-3
  • guidelines 28(3) 73-5
  • letter 28(6) 136-9
  • management of chronic obstructive pulmonary disease 24(6) 152-5
  • varenicline - Champix (New drug) 31(1) 24-7
  • snake bites
  • management 29(5) 125-9
  • sodium
  • drug-induced hyponatraemia 26(5) 114-7
  • letters 27(3) 55-7; 27(2) 28-33
  • sodium chloride
  • dietary - in renal calculi 19(4) 94-7
  • sodium cromoglycate
  • eye drops in conjunctivitis (PBAC question) 18(1) 12
  • Intal CFC-free (New formulation) 27(5) 131-3
  • sodium tetradecyl sulfate
  • Fibro-vein (New strength) 23(6) 137-9
  • sodium valproate
  • see valproic acid 30(3) 70-3; 17(1) 9-12
  • soft tissue infections
  • flucloxacillin vs other antibiotics (editorial) 18(3) 54-6
  • letter 19(1) 3-6
  • Solian
  • see amisulpride 27(3) 76-9; 25(5) 120-3
  • solifenacin succinate
  • Vesicare - overactive bladder (New drug) 29(5) 138-43
  • Somac
  • see pantoprazole 23(4) 84-7; 19(1) 24-7
  • somatostatin analogues
  • lanreotide - acromegaly - Somatuline LA (New drug) 25(2) 44-7
  • Somatuline LA
  • see lanreotide 25(2) 44-7
  • sorafenib
  • Nexavar - renal cell cancer (New drug) 29(6) 167-71
  • renal cell cancer 29(6) 151-3
  • sorbide nitrate
  • see isosorbide dinitrate 17(2) 30-2
  • Sorbidin
  • see isosorbide dinitrate 17(2) 30-2
  • sorbitol
  • in activated charcoal poisoning treatment 20(1) 14-6
  • Sotacor
  • see sotalol hydrochloride 23(6) 137-9
  • sotalol
  • DBL sotalol (New brand) 22(6) 147-51
  • Sotacor (New strength) 23(6) 137-9
  • sperm testing
  • fertility testing - abnormal laboratory results 25(2) 38-40
  • spider bites
  • management 29(6) 156-8
  • Spiractin
  • see spironolactone 18(1) 7-9
  • Spiriva
  • see tiotropium bromide 26(1) 22-3
  • spirometry
  • respiratory function tests 23(1) 10-2
  • dental notes 23(1) 21
  • spironolactone
  • in heart failure 23(6) 118-20
  • new brand - Spiractin 18(1) 7-9
  • polycystic ovary syndrome 27(5) 129-31
  • Sporanox
  • see itraconazole 21(3) 80-3; 17(4) 87-90
  • sport
  • anti-doping code 27(4) 84-7
  • Australian Sports Commission Medical Advisory Panel
  • letter 18(3) 56-7
  • doping (editorial) 17(4) 78-9
  • drugs 23(4) 76-8
  • letter 23(5) 93-6
  • Sprycel
  • see dasatinib 30(2) 50-55
  • St John's wort
  • as antidepressant 22(5) 112-3
  • letter 23(1) 5
  • complementary medicines safety (editorial) 25(3) 50-1
  • in mild depression 28(1) 8-10
  • warfarin interactions 25(3) 54-6
  • staphylococcal infections
  • community-acquired methicillin-resistant infection 28(6) 155
  • letter 29(3) 59-62
  • flucloxacillin vs other antibiotics (editorial) 18(3) 54-6
  • letter 19(1) 3-6
  • rifampicin and MRSA infections - Orphan Drug Scheme (letter) 29(1) 3-5
  • teicoplanin - Targocid (New drug) 18(1) 7-9
  • starter packs
  • adverse effects 30(1) 14-16
  • statins - see antilipidaemic drugs
    statistics
  • book review - 'Statistics with common sense' 27(3) 66
  • interpreting risks and ratios in clinical trials 31(1) 12-6
  • number needed to treat 23(2) 38
  • letters 24(3) 51-5; 23(6) 115-7
  • stavudine
  • HIV - Zerit (New drug) 19(3) 81-3
  • HIV - Zerit (New formulation) 22(4) 95-8
  • stem cell transplantation
  • adult leukaemia 29(3) 76-9
  • ancestim - Stemgen (New drug) 23(6) 137-9
  • letter 24(2) 27-8
  • Stemgen
  • see ancestim 24(2) 27-8; 23(6) 137-9
  • steroids - see corticosteroids
    Stilnox
  • see zolpidem 24(1) 20-3
  • stimulants
  • attention deficit hyperactivity disorder 18(3) 60-3
  • letters 19(3) 59-62; 19(2) 36-8; 19(1) 3-6
  • sport 23(4) 76-8
  • letter 23(5) 93-6
  • stingrays
  • management of stings 30(5) 117-21
  • Stocrin
  • see efavirenz 25(6) 147-51; 22(6) 147-51
  • Strattera
  • see atomoxetine 27(4) 101-5
  • Strepfen
  • see flurbiprofen 24(2) 43-7
  • streptococcal infections
  • flucloxacillin vs other antibiotics (editorial) 18(3) 54-6
  • letter 19(1) 3-6
  • phenoxymethylpenicillin in S. pyogenes infection (PBAC question) 19(1) 6-7
  • letter 19(4) 92-3
  • pneumonia - vaccination - recommendations 17(2) 41
  • teicoplanin - Targocid (New drug) 18(1) 7-9
  • stress
  • post-traumatic stress disorder 22(2) 32-4
  • letters 22(5) 103-5
  • stress testing
  • coronary disease 17(3) 57-61
  • diabetes - exercise 30(5) 130-3
  • stroke - see cerebrovascular disorders
    Stromectol
  • see ivermectin 22(6) 147-51; 20(3) 77-9
  • strongylodiasis
  • ivermectin - Stromectol (New drug) 20(3) 77-9
  • strontium ranelate
  • Protos - postmenopausal osteoporosis (New drug) 28(6) 156-8
  • struvite
  • renal calculi 19(4) 94-7
  • subarachnoid haemorrhage
  • tirilazad mesylate - Freedox (New drug) 20(2) 45-51
  • Subutex
  • see buprenorphine 24(3) 71-5
  • suicide
  • risk in children (editorials) 28(5) 110-1; 28(5) 111-3
  • letter 29(2) 32-5
  • sulesomab
  • osteomyelitis diagnosis - LeukoScan (New drug) 25(3) 74-5
  • sulfadiazine
  • ocular toxoplasmosis 25(4) 88-90
  • letter 26(3) 51-2
  • sulfasalazine
  • in adult rheumatoid arthritis 26(2) 36-40
  • letter 26(4) 75-7
  • sulfonamides
  • allergy and cross-reactivity 31(1) 8-10
  • sulfonylureas
  • drug interactions 24(4) 83-5
  • glimepiride - type 2 diabetes - Amaryl (New drug) 24(3) 71-5
  • thiazolidinediones 27(3) 70-4
  • in type 2 diabetes 20(3) 65-7
  • sulphamethoxazole
  • see trimethoprim with sulphamethoxazole 19(2) 47
  • sumatriptan
  • 50mg tablets (PBAC question) 20(4) 86-7
  • letter 21(3) 60-3
  • migraine - Imigran (New formulation) 21(4) 108-11
  • migraine - Imigran (New strength) 19(2) 38-40
  • sunitinib
  • renal cell cancer 29(6) 151-3
  • Sutent - gastrointestinal stromal tumour, renal cell cancer (New drug) 29(6) 167-71
  • surgery
  • anaesthesia and perioperative care of the aged 25(2) 42-4
  • antibiotics for surgical prophylaxis 28(2) 38-40
  • dental notes 28(2) 41
  • letters 28(5) 113-5; 28(3) 55-8
  • blood transfusion guidelines 28(2) 45-7
  • desirudin - hip surgery - Revasc (New drug) 23(6) 137-9
  • dexmedetomidine - postoperative sedation - Precedex (New drug) 24(5) 129-31
  • hydrogen peroxide in wound debridement (letter) 19(3) 59-62
  • nutrition and surgical outcomes 26(6) 136-40
  • perioperative analgesia 27(6) 152-4
  • letter 28(2) 29-33
  • perioperative anticoagulation 23(1) 13-6
  • letter 23(4) 72
  • surgical wound dressings and healing 19(1) 11-3
  • Survanta
  • see modified bovine lung extract (beractant) 18(1) 7-9
  • Sutent
  • see sunitinib 29(6) 167-71
  • Synagis
  • see palivizumab 22(5) 125-7
  • Synarel
  • see nafarelin 17(2) 30-2
  • Synercid IV
  • see quinupristin/dalfospristin 23(3) 64-7
  • syphilis
  • abnormal laboratory results 30(1) 8-13
  • syringe pumps
  • guidelines 18(2) 49-51
  • syringes - see also injections
  • needle changing (letters) 22(2) 28-31; 21(3) 60-3
  • systematic reviews
  • systematic reviews 24(4) 78-9; 20(4) 93-6
  • systemic effects
  • miconazole oral gel (medicinal mishap) 26(2) 35
  • systemic lupus erythematosus
  • lupus support groups - patient support organisations 17(3) 61
  • Home     Contact Us     Useful Links     Copyright     Privacy     Web Manager